CMS is pleased to announce the appointment of Amélie Chollet as partner in its Life Sciences & Healthcare group in London. Amélie’s appointment is part of CMS’s strategic plan to strengthen its life sciences regulatory practice and support the firm’s growth in this critical sector.
Amélie joins the firm from Abbott Laboratories where she was Legal Regulatory Counsel. She has an established profile as a strategic life sciences regulatory advisor, and brings over 10 years’ experience advising on multijurisdictional regulatory matters for leading global life sciences companies.
Sarah Hanson, CMS Partner and Co-Head of the Life Sciences & Healthcare Group, adds: Amélie’s deep understanding of the life sciences regulatory environment and her extensive experience delivering practical, business-oriented solutions will complement and enhance our service offering. Her expertise in digital health, ESG and regulatory compliance will be particularly beneficial to our clients. Amélie also brings with her an insider’s understanding of our client’s commercial drivers, and we’re excited to add this perspective to the team.
The CMS Lifesciences & Healthcare team has many years of advising and shaping the sector through its deep industry experience and wide range of services.
John Enser, CMS Partner and Head of the Technology, Media, IP and Competition Practice Group, comments: “We are thrilled to welcome Amélie to the firm. Her extensive experience in the life sciences sector, particularly in regulatory compliance and strategic advisory, will be invaluable as we continue to expand our capabilities and support our clients in navigating the evolving regulatory landscape.”
Amélie Chollet adds: “I’m excited to join CMS's exceptional team, bringing my decade of senior in-house experience to help clients navigate the increasingly complex regulatory landscape in life sciences. Having sat on both sides of the table, I understand the practical challenges organisations face and look forward to delivering solutions that bridge technical requirements with commercial realities.’’
Amélie’s appointment follows the recent hire of a team of product liability specialists in London, led by partners Simon Castley and Sarah Croft.
CMS is one of the largest firms operating in the sector, with over 480+ global life sciences & healthcare specialists, and top rankings for life sciences & healthcare in both Chambers & Partners and Legal 500. The group’s services cover complex regulatory product liability, competition, procurement, commercial and IP issues, as well as disputes, M&A and financing. The firm’s clients include the global top 20 pharmaceutical and the top 10 medical device companies.
This news story was originally published on the firm’s website.